Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Nils P. Krone"'
Autor:
Helen Eachus, Lara Oberski, Jack Paveley, Irina Bacila, John-Paul Ashton, Umberto Esposito, Fayaz Seifuddin, Mehdi Pirooznia, Eran Elhaik, Marysia Placzek, Nils P. Krone, Vincent T. Cunliffe
Publikováno v:
Disease Models & Mechanisms, Vol 16, Iss 9 (2023)
Externí odkaz:
https://doaj.org/article/aa67d866b66e45b491817fdc22250015
Autor:
Uta Neumann, Annelieke van der Linde, Ruth E Krone, Nils P Krone, Ayla Güven, Tülay Güran, Heba Elsedfy, Sukran Poyrazoglu, Feyza Darendeliler, Tania A S S Bachega, Antonio Balsamo, Sabine E Hannema, Niels Birkebaek, Ana Vieites, Ajay Thankamony, Martine Cools, Tatjana Milenkovic, Walter Bonfig, Eduardo Correa Costa, Navoda Atapattu, Liat de Vries, Guilherme Guaragna-Filho, Marta Korbonits, Klaus Mohnike, Jillian Bryce, S Faisal Ahmed, Bernard Voet, Oliver Blankenstein, Hedi L Claahsen-van der Grinten
Publikováno v:
Neumann, U, van der Linde, A, Krone, R E, Krone, N P, Güven, A, Güran, T, Elsedfy, H, Poyrazoglu, S, Darendeliler, F, Bachega, T A, Balsamo, A, Hannema, S E, Birkebæk, N, Vieites, A, Thankamony, A, Cools, M, Milenkovic, T, Bonfig, W, Costa, E C, Atapattu, N, de Vries, L, Guaragna-Filho, G, Korbonits, M, Mohnike, K, Bryce, J, Ahmed, S F, Voet, B, Blankenstein, O & Claahsen-van der Grinten, H L 2022, ' Treatment of congenital adrenal hyperplasia in children aged 0-3 years : A retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure ', European Journal of Endocrinology, vol. 187, no. 2, pp. 587-596 . https://doi.org/10.1530/EJE-21-1085
European Journal of Endocrinology, 187(2), 587-596. BioScientifica Ltd.
Neumann, U, van der Linde, A, Krone, R E, Krone, N P, Güven, A, Güran, T, Elsedfy, H, Poyrazoglu, S, Darendeliler, F, Bachega, T A S S, Balsamo, A, Hannema, S E, Birkebaek, N, Vieites, A, Thankamony, A, Cools, M, Milenkovic, T, Bonfig, W, Costa, E C, Atapattu, N, de Vries, L, Guaragna-Filho, G, Korbonits, M, Mohnike, K, Bryce, J, Ahmed, S F, Voet, B, Blankenstein, O & Claahsen-van der Grinten, H L 2022, ' Treatment of congenital adrenal hyperplasia in children aged 0-3 years : a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure ', European Journal of Endocrinology, vol. 186, no. 5, pp. 587-596 . https://doi.org/10.1530/EJE-21-1085
EUROPEAN JOURNAL OF ENDOCRINOLOGY
European Journal of Endocrinology, 186(5), 587-596. Bioscientifica Ltd
European Journal of Endocrinology, 186, 587-596
European Journal of Endocrinology, 186, 5, pp. 587-596
European Journal of Endocrinology, 187(2), 587-596. BioScientifica Ltd.
Neumann, U, van der Linde, A, Krone, R E, Krone, N P, Güven, A, Güran, T, Elsedfy, H, Poyrazoglu, S, Darendeliler, F, Bachega, T A S S, Balsamo, A, Hannema, S E, Birkebaek, N, Vieites, A, Thankamony, A, Cools, M, Milenkovic, T, Bonfig, W, Costa, E C, Atapattu, N, de Vries, L, Guaragna-Filho, G, Korbonits, M, Mohnike, K, Bryce, J, Ahmed, S F, Voet, B, Blankenstein, O & Claahsen-van der Grinten, H L 2022, ' Treatment of congenital adrenal hyperplasia in children aged 0-3 years : a retrospective multicenter analysis of salt supplementation, glucocorticoid and mineralocorticoid medication, growth and blood pressure ', European Journal of Endocrinology, vol. 186, no. 5, pp. 587-596 . https://doi.org/10.1530/EJE-21-1085
EUROPEAN JOURNAL OF ENDOCRINOLOGY
European Journal of Endocrinology, 186(5), 587-596. Bioscientifica Ltd
European Journal of Endocrinology, 186, 587-596
European Journal of Endocrinology, 186, 5, pp. 587-596
Objectives International guidelines recommend additional salt supplementation during infancy in classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency. The influence of corticoid medication and growth has not been assessed. Aim
Autor:
Salma Rashid Ali, Jillian Bryce, Nils P. Krone, Hedi L. Claahsen-van der Grinten, S.Faisal Ahmed
Publikováno v:
Hormone Research in Paediatrics, 95, 363-373
Hormone Research in Paediatrics, 95, 4, pp. 363-373
Hormone Research in Paediatrics, 95, 4, pp. 363-373
Introduction: There is wide variation in reported rates of acute adrenal insufficiency (AI)-related adverse events (sick day episodes and adrenal crises) between centres. This study aimed to evaluate the level of consensus on criteria considered esse
Autor:
Irina Bacila, Neil Richard Lawrence, Sundus Mahdi, Sabah Alvi, Timothy D Cheetham, Elizabeth Crowne, Urmi Das, Mehul Tulsidas Dattani, Justin H Davies, Evelien Gevers, Ruth E Krone, Andreas Kyriakou, Leena Patel, Tabitha Randell, Fiona J Ryan, Brian Keevil, S Faisal Ahmed, Nils P Krone
Objective There is limited knowledge on the onset of comorbidities in congenital adrenal hyperplasia (CAH) during childhood. We aimed to establish the health status of children with CAH in the UK. Design and methods This cross-sectional multicentre s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c6f69a1b3947309fe9f6f8423f9fc79
https://eprints.gla.ac.uk/278355/1/278355.pdf
https://eprints.gla.ac.uk/278355/1/278355.pdf
Publikováno v:
The Lancet. 397:613-629
Adrenal insufficiency can arise from a primary adrenal disorder, secondary to adrenocorticotropic hormone deficiency, or by suppression of adrenocorticotropic hormone by exogenous glucocorticoid or opioid medications. Hallmark clinical features are u
Autor:
Nils P. Krone
Congenital adrenal hyperplasia (CAH) comprises a group of autosomal recessive disorders causing impaired cortisol biosynthesis. The phenotypic expression of different CAH forms depends on the underlying enzyme deficiency. Steroid 21-hydroxylase (CYP2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2d9c4b147e8505dee045f5a74a68fc85
https://doi.org/10.1093/med/9780198870197.003.0104
https://doi.org/10.1093/med/9780198870197.003.0104
Autor:
Nils P. Krone, Ieuan A. Hughes
Congenital adrenal hyperplasia (CAH) results from enzymatic defects in the pathways of adrenal steroidogenesis, with over 90% of cases being due to 21-hydroxylase deficiency caused by autosomal recessive mutations in the CYP21A2 gene. Management requ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2ce5aea799a0b1fe146a80e49f57c872
https://doi.org/10.1093/med/9780198746690.003.0250
https://doi.org/10.1093/med/9780198746690.003.0250